Skip to main content

In a study involving 66 participants were randomly assigned to one of three groups: placebo; Bifidobacterium animalis BL04 (B. lactis BL04) 1 billion CFU; or B. lactis BL04 (1 billion CFU) plus PreforPro® (15mg). Participants consumed one capsule per day for four weeks. The outcomes sought were impacts on GI discomfort as well as changes or modulation of the gut microbiota.

Overall, the researchers found that the individuals in the B. lactis plus PreforPro® group showed the following:

  • Improvements in self-reported GI inflammation symptoms
  • Reduction in colonic cramp discomfort
  • Greater increase in the presence of Lactobacillus vs. placebo
  • Decrease of strains Citrobacter and Desulfovibrio, which are associated with gut inflammation and GI disorders
  • Reduction in E. coli

In conclusion, the study demonstrates that supplementing B. lactis BL04 with PreforPro® can significantly modulate gut ecology to favor beneficial bacteria.

VIEW PUBLISHED STUDY

More Resources

Human Clinical Study: Prebiotic PreforPro® Shown to Positively Impact Gut Microbiota
In a study involving 43 participants aged 18-65, researchers found that 28-days of PreforPro consumption favorably modified several bacterial species,…
More
Clinical Study: Prebiotic PreforPro® Shows Synbiotic Benefits for GI Function
In a study involving 66 participants were randomly assigned to one of three groups: placebo; Bifidobacterium animalis BL04 (B. lactis BL04) 1 billion…
More